ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab (IgES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01436617
Recruitment Status : Completed
First Posted : September 19, 2011
Last Update Posted : March 8, 2013
Sponsor:
Collaborator:
University Hospital, Caen
Information provided by (Responsible Party):
Centre Francois Baclesse

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : March 2013